Qosina Explains Expansion into the Bioprocess Market
The Evolution of Single-use Systems for the Bioprocess Industry and Emergence of Unmet Needs. Learn about early players in the single-use systems market, lessons learned, and how the industry has evolved.
Click here to read our bioprocess blog,
Three Error Proofing Strategies for Single-Use Systems
Human error is a determining factor in a large percentage of adverse events experienced in healthcare. Single-use bioprocessing is also vulnerable to human error, and while the consequences may not be as grave, this industry can learn from the medical device industry on proven techniques for error prevention. Using lessons learned and best practices, discover demonstrated error-proofing steps to eliminate risk or potential misconnections when designing single-use systems.
Qosina explains expansion into the advanced therapies market
From the Qosina exhibit at Advanced Therapies Week 2022, Paul Priebe, Vice President of Business Development and New Markets discusses the strengths and deep knowledge that Qosina brings to the medical devices and bioprocessing industries and how it can be applied within the advanced therapies segment.